Enanta Pharmaceuticals, Inc.
ENTAHealthcare|Biotechnology|US
$11.00
+0.92 (+9.13%)
Tangible Book / Share
$3.47
Cash / Share
$6.51
Ownership Breakdown
95.3%
Float
29.1M
Shares Outstanding
27.7M
Float Shares
Major Holders (30)
Combined: 210.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | IA, HC | 12.10% | 3,494,068 | Nov 7, 2025 | 13D/G |
| Janus Henderson Biotech Innovation Master Fund Ltd | Investment company | 10.60% | 2,959,525 | Nov 7, 2025 | 13D/G |
| Luo Patrick (Cheng) | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Farallon Capital Management, L.L.C. | IA, OO | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Dapice Joshua J. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Dreyfuss, Philip D. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Dunn Hannah E. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Gehani, Varun N. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Giauque, Nicolas | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Husen, Avner A. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Kim, David T. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Linn, Michael G. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Roberts, Jr., Thomas G. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Saito Edric C. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Short Daniel S. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Spokes, Andrew J. M. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Warren, John R. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| Wehrly, Mark C. | HC, IN | 8.30% | 2,418,202 | Aug 14, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 7.80% | 1,673,483 | Apr 17, 2025 | 13D/G |
| Jay R. Luly, Ph.D. | Individual | 7.70% | 1,703,616 | Feb 14, 2025 | 13D/G |
| BlackRock Portfolio Management LLC | Holding company | 5.40% | 1,560,091 | Oct 27, 2026 | 13D/G |
| Deep Track Capital, LP | IA, OO | 4.97% | 1,444,167 | Aug 14, 2026 | 13D/G |
| Deep Track Biotechnology Master Fund, Ltd. | Corporation | 4.97% | 1,444,167 | Aug 14, 2026 | 13D/G |
| David Kroin | HC, IN | 4.97% | 1,444,167 | Aug 14, 2026 | 13D/G |
| Armistice Capital, LLC | IA, OO | 4.72% | 1,000,000 | Nov 14, 2024 | 13D/G |
| Steven Boyd | HC, IN | 4.72% | 1,000,000 | Nov 14, 2024 | 13D/G |
| Millennium Group Management LLC | Other | 2.30% | 670,428 | Jan 20, 2026 | 13D/G |
| Millennium Management LLC | Other | 2.30% | 670,428 | Jan 20, 2026 | 13D/G |
| Integrated Core Strategies (US) LLC | Other | 2.30% | 665,953 | Jan 20, 2026 | 13D/G |
| Israel A. Englander | Individual | 2.30% | 670,428 | Jan 20, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,011,243 acquired · 42,043 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Rottinghaus Scott T. | Chief Medical Officer | Aug 8, 2026 | TAX W/H | 1,467 | $13.34 | $19.6K | Form 4 |
| Vance Terry | director | Mar 11, 2026 | AWARD | 20,000 | $14.17 | $283.4K | Form 4 |
| Russell Lesley | director | Mar 11, 2026 | AWARD | 20,000 | $14.17 | $283.4K | Form 4 |
| Peterson Kristine | director | Mar 11, 2026 | AWARD | 20,000 | $14.17 | $283.4K | Form 4 |
| Hata Yujiro S | director | Mar 11, 2026 | AWARD | 20,000 | $14.17 | $283.4K | Form 4 |
| FOLETTA MARK G | director | Mar 11, 2026 | AWARD | 20,000 | $14.17 | $283.4K | Form 4 |
| CARTER BRUCE L A | director | Mar 11, 2026 | AWARD | 20,000 | $14.17 | $283.4K | Form 4 |
| Kowalsky Matthew Paul | Chief Legal Officer | Feb 12, 2026 | AWARD | 4,175 | — | — | Form 4 |
| Kowalsky Matthew Paul | Chief Legal Officer | Feb 12, 2026 | TAX W/H | 1,902 | $14.25 | $27.1K | Form 4 |
| Kowalsky Matthew Paul | Chief Legal Officer | Feb 12, 2026 | AWARD | 1,318 | — | — | Form 4 |
| Luu Brendan | Chief Business Officer | Feb 12, 2026 | AWARD | 4,987 | — | — | Form 4 |
| Luu Brendan | Chief Business Officer | Feb 12, 2026 | TAX W/H | 3,257 | $14.25 | $46.4K | Form 4 |
| Luu Brendan | Chief Business Officer | Feb 12, 2026 | AWARD | 1,575 | — | — | Form 4 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Feb 12, 2026 | AWARD | 4,987 | — | — | Form 4 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Feb 12, 2026 | TAX W/H | 3,257 | $14.25 | $46.4K | Form 4 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Feb 12, 2026 | AWARD | 1,575 | — | — | Form 4 |
| Rottinghaus Scott T. | Chief Medical Officer | Feb 12, 2026 | AWARD | 5,225 | — | — | Form 4 |
| Rottinghaus Scott T. | Chief Medical Officer | Feb 12, 2026 | TAX W/H | 3,413 | $14.25 | $48.6K | Form 4 |
| Rottinghaus Scott T. | Chief Medical Officer | Feb 12, 2026 | AWARD | 1,650 | — | — | Form 4 |
| Or Yat Sun | Chief Scientific Officer | Feb 12, 2026 | AWARD | 5,225 | — | — | Form 4 |
| Or Yat Sun | Chief Scientific Officer | Feb 12, 2026 | TAX W/H | 3,413 | $14.25 | $48.6K | Form 4 |
| Or Yat Sun | Chief Scientific Officer | Feb 12, 2026 | AWARD | 1,650 | — | — | Form 4 |
| Luly Jay R. | director, officer: President and CEO | Feb 12, 2026 | AWARD | 15,200 | — | — | Form 4 |
| Luly Jay R. | director, officer: President and CEO | Feb 12, 2026 | TAX W/H | 6,155 | $14.25 | $87.7K | Form 4 |
| Luly Jay R. | director, officer: President and CEO | Feb 12, 2026 | AWARD | 4,800 | — | — | Form 4 |
| Capps Kathleen S. | See Remarks | Dec 5, 2025 | SELL | 323 | $14.23 | $4.6K | Form 4 |
| Trout Harry R. III | See Remarks | Dec 5, 2025 | SELL | 542 | $14.23 | $7.7K | Form 4 |
| Rottinghaus Scott T. | Chief Medical Officer | Dec 5, 2025 | SELL | 798 | $14.23 | $11.4K | Form 4 |
| Luu Brendan | Chief Business Officer | Dec 5, 2025 | SELL | 1,394 | $14.23 | $19.8K | Form 4 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Dec 5, 2025 | SELL | 2,106 | $14.23 | $30.0K | Form 4 |
| Or Yat Sun | Chief Scientific Officer | Dec 5, 2025 | SELL | 2,390 | $14.23 | $34.0K | Form 4 |
| Luly Jay R. | director, officer: President and CEO | Dec 5, 2025 | SELL | 4,743 | $14.23 | $67.5K | Form 4 |
| Capps Kathleen S. | See Remarks | Dec 1, 2025 | TAX W/H | 85 | $14.12 | $1.2K | Form 4 |
| Capps Kathleen S. | See Remarks | Dec 2, 2025 | SELL | 207 | $13.96 | $2.9K | Form 4 |
| Trout Harry R. III | See Remarks | Dec 1, 2025 | TAX W/H | 105 | $14.12 | $1.5K | Form 4 |
| Trout Harry R. III | See Remarks | Dec 2, 2025 | SELL | 380 | $13.96 | $5.3K | Form 4 |
| Luu Brendan | Chief Business Officer | Dec 1, 2025 | TAX W/H | 498 | $14.12 | $7.0K | Form 4 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Dec 1, 2025 | TAX W/H | 753 | $14.12 | $10.6K | Form 4 |
| Or Yat Sun | Chief Scientific Officer | Dec 1, 2025 | TAX W/H | 753 | $14.12 | $10.6K | Form 4 |
| Luly Jay R. | director, officer: President and CEO | Dec 1, 2025 | TAX W/H | 1,885 | $14.12 | $26.6K | Form 4 |
| Capps Kathleen S. | See Remarks | Nov 25, 2025 | AWARD | 3,163 | — | — | Form 4 |
| Capps Kathleen S. | See Remarks | Nov 25, 2025 | AWARD | 6,325 | $13.66 | $86.4K | Form 4 |
| Trout Harry R. III | See Remarks | Nov 25, 2025 | AWARD | 6,463 | — | — | Form 4 |
| Trout Harry R. III | See Remarks | Nov 25, 2025 | AWARD | 12,925 | $13.66 | $176.6K | Form 4 |
| Luu Brendan | Chief Business Officer | Nov 25, 2025 | AWARD | 90,000 | $13.66 | $1.2M | Form 4 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Nov 25, 2025 | AWARD | 100,000 | $13.66 | $1.4M | Form 4 |
| Kowalsky Matthew Paul | Chief Legal Officer | Nov 25, 2025 | AWARD | 90,000 | $13.66 | $1.2M | Form 4 |
| Rottinghaus Scott T. | Chief Medical Officer | Nov 25, 2025 | AWARD | 110,000 | $13.66 | $1.5M | Form 4 |
| Or Yat Sun | Chief Scientific Officer | Nov 25, 2025 | AWARD | 110,000 | $13.66 | $1.5M | Form 4 |
| Luly Jay R. | director, officer: President and CEO | Nov 25, 2025 | AWARD | 310,000 | $13.66 | $4.2M | Form 4 |
| Capps Kathleen S. | See Remarks | Aug 26, 2025 | OTHER | 0 | — | — | Form 4 |
| Capps Kathleen S. | See Remarks | Aug 26, 2025 | OTHER | 5,402 | $43.57 | $235.4K | Form 4 |
| Capps Kathleen S. | See Remarks | Aug 26, 2025 | OTHER | 5,950 | $48.52 | $288.7K | Form 4 |
| Capps Kathleen S. | See Remarks | Aug 26, 2025 | OTHER | 3,482 | $45.00 | $156.7K | Form 4 |
| Capps Kathleen S. | See Remarks | Aug 26, 2025 | OTHER | 5,250 | $8.99 | $47.2K | Form 4 |
| Capps Kathleen S. | See Remarks | Aug 26, 2025 | OTHER | 5,513 | $8.83 | $48.7K | Form 4 |
| Capps Kathleen S. | See Remarks | Aug 26, 2025 | OTHER | 497 | $29.68 | $14.8K | Form 4 |
| Capps Kathleen S. | See Remarks | Aug 26, 2025 | OTHER | 7,000 | $81.20 | $568.4K | Form 4 |
| Capps Kathleen S. | See Remarks | Aug 26, 2025 | OTHER | 4,914 | $75.33 | $370.2K | Form 4 |
| Capps Kathleen S. | See Remarks | Aug 26, 2025 | OTHER | 2,668 | $30.00 | $80.0K | Form 4 |
| Capps Kathleen S. | See Remarks | Aug 26, 2025 | OTHER | 8,125 | $63.35 | $514.7K | Form 4 |
| Trout Harry R. III | Vice President, Finance | Aug 26, 2025 | OTHER | 0 | — | — | Form 4 |
| Trout Harry R. III | Vice President, Finance | Aug 26, 2025 | OTHER | 7,110 | $81.20 | $577.3K | Form 4 |
| Trout Harry R. III | Vice President, Finance | Aug 26, 2025 | OTHER | 6,048 | $75.33 | $455.6K | Form 4 |
| Trout Harry R. III | Vice President, Finance | Aug 26, 2025 | OTHER | 5,571 | $45.00 | $250.7K | Form 4 |
| Trout Harry R. III | Vice President, Finance | Aug 26, 2025 | OTHER | 4,987 | $43.57 | $217.3K | Form 4 |
| Trout Harry R. III | Vice President, Finance | Aug 26, 2025 | OTHER | 9,075 | $8.99 | $81.6K | Form 4 |
| Trout Harry R. III | Vice President, Finance | Aug 26, 2025 | OTHER | 10,175 | $8.83 | $89.8K | Form 4 |
| Trout Harry R. III | Vice President, Finance | Aug 26, 2025 | OTHER | 10,000 | $63.35 | $633.5K | Form 4 |
| Rottinghaus Scott T. | Chief Medical Officer | Aug 8, 2025 | TAX W/H | 2,217 | $6.99 | $15.5K | Form 4 |
| Vance Terry | director | Mar 13, 2025 | AWARD | 15,700 | $6.83 | $107.2K | Form 4 |
| Russell Lesley | director | Mar 13, 2025 | AWARD | 15,700 | $6.83 | $107.2K | Form 4 |
| Peterson Kristine | director | Mar 13, 2025 | AWARD | 15,700 | $6.83 | $107.2K | Form 4 |
| Hata Yujiro S | director | Mar 13, 2025 | AWARD | 15,700 | $6.83 | $107.2K | Form 4 |
| FOLETTA MARK G | director | Mar 13, 2025 | AWARD | 15,700 | $6.83 | $107.2K | Form 4 |
| CARTER BRUCE L A | director | Mar 13, 2025 | AWARD | 15,700 | $6.83 | $107.2K | Form 4 |
| Luu Brendan | Chief Business Officer | Feb 12, 2025 | AWARD | 7,500 | — | — | Form 4 |
| Luu Brendan | Chief Business Officer | Feb 12, 2025 | TAX W/H | 3,326 | $5.59 | $18.6K | Form 4 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Feb 12, 2025 | AWARD | 7,500 | — | — | Form 4 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Feb 12, 2025 | TAX W/H | 3,326 | $5.59 | $18.6K | Form 4 |
| Rottinghaus Scott T. | Chief Medical Officer | Feb 12, 2025 | AWARD | 9,750 | — | — | Form 4 |
| Rottinghaus Scott T. | Chief Medical Officer | Feb 12, 2025 | TAX W/H | 2,861 | $5.59 | $16.0K | Form 4 |
| Or Yat Sun | Chief Scientific Officer | Feb 12, 2025 | AWARD | 9,750 | — | — | Form 4 |
| Or Yat Sun | Chief Scientific Officer | Feb 12, 2025 | TAX W/H | 4,324 | $5.59 | $24.2K | Form 4 |
| MELLETT PAUL J | Chief Fin. & Admin Officer | Feb 12, 2025 | AWARD | 7,500 | — | — | Form 4 |
| MELLETT PAUL J | Chief Fin. & Admin Officer | Feb 12, 2025 | TAX W/H | 3,326 | $5.59 | $18.6K | Form 4 |
| Luly Jay R. | director, officer: President and CEO | Feb 12, 2025 | AWARD | 25,500 | — | — | Form 4 |
| Luly Jay R. | director, officer: President and CEO | Feb 12, 2025 | TAX W/H | 7,484 | $5.59 | $41.8K | Form 4 |
| Luly Jay R. | director, officer: President and CEO | Feb 12, 2025 | BUY | 45,000 | $5.69 | $256.1K | Form 4 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Dec 6, 2024 | SELL | 2,283 | $8.06 | $18.4K | Form 4 |
| Luu Brendan | Chief Business Officer | Dec 6, 2024 | SELL | 2,283 | $8.06 | $18.4K | Form 4 |
| Rottinghaus Scott T. | Chief Medical Officer | Dec 6, 2024 | SELL | 866 | $8.06 | $7.0K | Form 4 |
| Or Yat Sun | Chief Scientific Officer | Dec 6, 2024 | SELL | 2,591 | $8.06 | $20.9K | Form 4 |
| MELLETT PAUL J | Chief Fin. & Admin Officer | Dec 6, 2024 | SELL | 2,591 | $8.06 | $20.9K | Form 4 |
| Luly Jay R. | director, officer: President and CEO | Dec 6, 2024 | SELL | 5,142 | $8.06 | $41.4K | Form 4 |
| Luu Brendan | Chief Business Officer | Dec 1, 2024 | TAX W/H | 753 | $8.60 | $6.5K | Form 4 |
| Kieffer Tara Lynn | Chief Product Strategy Officer | Dec 1, 2024 | TAX W/H | 753 | $8.60 | $6.5K | Form 4 |
| Or Yat Sun | Chief Scientific Officer | Dec 1, 2024 | TAX W/H | 1,595 | $8.60 | $13.7K | Form 4 |
| MELLETT PAUL J | Chief Fin. & Admin Officer | Dec 1, 2024 | TAX W/H | 1,595 | $8.60 | $13.7K | Form 4 |
| Luly Jay R. | director, officer: President and CEO | Dec 1, 2024 | TAX W/H | 3,829 | $8.60 | $32.9K | Form 4 |
Congress & Senate Trades (1)
Daniel GoldmanHouse · NY10Jul 12, 2023